Cargando…

Disappearing acts of ADAMTS13

Detalles Bibliográficos
Autores principales:	Voorberg, Jan, Verbij, Fabian C., Fijnheer, Rob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563130/ https://www.ncbi.nlm.nih.gov/pubmed/26425683 http://dx.doi.org/10.1016/j.ebiom.2015.07.013

Ejemplares similares

Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ
por: Hrdinová, Johana, et al.
Publicado: (2018)

Von Willebrand factor, ADAMTS13 and mortality in dialysis patients
por: Ocak, Gurbey, et al.
Publicado: (2021)

Conformational plasticity of ADAMTS13 in hemostasis and autoimmunity
por: Ercig, Bogac, et al.
Publicado: (2021)

Generation and validation of small ADAMTS13 fragments for epitope mapping of anti‐ADAMTS13 autoantibodies in immune‐mediated thrombotic thrombocytopenic purpura
por: Kangro, Kadri, et al.
Publicado: (2020)

Can ADAMTS13 Lead Us to the Paradise of Personalized Medicine?
por: Rossing, Peter, et al.
Publicado: (2013)

Antimatters Disappearing Act
por: Doser, Michael
Publicado: (2017)

Shedding Light on the Possible Link between ADAMTS13 and Vaccine—Induced Thrombotic Thrombocytopenia
por: Szóstek-Mioduchowska, Anna, et al.
Publicado: (2021)

Severe Dengue Is Associated with Consumption of von Willebrand Factor and Its Cleaving Enzyme ADAMTS-13
por: Djamiatun, Kis, et al.
Publicado: (2012)

Altered VWF:ADAMTS13 homeostasis is a target for therapeutic intervention in sickle cell disease
por: Chaturvedi, Shruti, et al.
Publicado: (2022)

Appearing and disappearing acts of cilia
por: Arora, Shashank, et al.
Publicado: (2023)

Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpura
por: Graça, Nuno A. G., et al.
Publicado: (2019)

ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Bonnez, Quintijn, et al.
Publicado: (2023)

ADAMTS13, TTP and Beyond
por: Zheng, X Long
Publicado: (2012)

Mechanisms of ADAMTS13 regulation
por: DeYoung, Veronica, et al.
Publicado: (2022)

Covid‐19 will not “magically disappear”: Why access to widespread testing is paramount
por: George, Paul E., et al.
Publicado: (2020)

Disappearing women, vanishing ladies and property in embryos
por: Dickenson, Donna L.
Publicado: (2017)

ADAMTS13 Deficiency Worsens Colitis and Exogenous ADAMTS13 Administration Decreases Colitis Severity in Mice
por: Zitomersky, Naamah L., et al.
Publicado: (2017)

As anonymity disappears the focus becomes limits on donor offspring
por: Nelson, Margaret K., et al.
Publicado: (2016)

Systemic antithrombotic effects of ADAMTS13
por: Chauhan, Anil K., et al.
Publicado: (2006)

Reduced ADAMTS13 activity is associated with an ADAMTS13 SNP, fever and microparticles in a malaria-like model
por: Kraisin, Sirima, et al.
Publicado: (2014)

Further characterization of ADAMTS-13 inactivation by thrombin
por: LAM, J K, et al.
Publicado: (2007)

Frequency of Pro475Ser Polymorphism of ADAMTS13 Gene and Its Association with ADAMTS-13 Activity in the Korean Population
por: Jang, Mun Ju, et al.
Publicado: (2008)

γδ T cells: A disappearing act with a big reveal
por: Jameson, Julie M.
Publicado: (2018)

Association of ADAMTS13 polymorphism with cerebral malaria
por: Kraisin, Sirima, et al.
Publicado: (2011)

ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies
por: Sarig, Galit
Publicado: (2014)

Recombinant ADAMTS 13 in thrombotic thrombocytopenic purpura
por: Scully, Marie, et al.
Publicado: (2017)

ADAMTS13: An Emerging Target in Stroke Therapy
por: Chen, Xin, et al.
Publicado: (2019)

Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis
por: Uemura, Masahito, et al.
Publicado: (2011)

Novel mutations in ADAMTS13 CUB domains cause abnormal pre‐mRNA splicing and defective secretion of ADAMTS13
por: Jiang, Yizhi, et al.
Publicado: (2020)

Optimization of anti-ADAMTS13 antibodies for the treatment of ADAMTS13-related bleeding disorder in patients receiving circulatory assist device support
por: Ito, Toshihiro, et al.
Publicado: (2021)

The role of ADAMTS13 in acute myocardial infarction: cause or consequence?
por: Eerenberg, Elise S., et al.
Publicado: (2016)

The disappearing act: case of a migrating left renal vein stent
por: Cooley, Christopher, et al.
Publicado: (2023)

Phenotypic Expression of ADAMTS13 in Glomerular Endothelial Cells
por: Tati, Ramesh, et al.
Publicado: (2011)

Conformational quiescence of ADAMTS‐13 prevents proteolytic promiscuity
por: South, K., et al.
Publicado: (2016)

Crystal structure and substrate-induced activation of ADAMTS13
por: Petri, Anastasis, et al.
Publicado: (2019)

ADAMTS‐13 and bleeding phenotype in von Willebrand disease
por: Boender, Johan, et al.
Publicado: (2020)

The von Willebrand factor – ADAMTS‐13 axis in malaria
por: O’Donnell, Andrew S., et al.
Publicado: (2022)

Assay for ADAMTS-13 Activity with Flow Cytometric Readout
por: Müller, Jens, et al.
Publicado: (2022)

Anti-ADAMTS13 Antibodies and a Novel Heterozygous p.R1177Q Mutation in a Case of Pregnancy-Onset Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Roose, Elien, et al.
Publicado: (2018)

Probing ADAMTS13 Substrate Specificity using Phage Display
por: Desch, Karl C., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cum43brh4qtqihud3mloqhlo44